GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » Scaled Net Operating Assets

Innovita Biological Technology Co (SHSE:688253) Scaled Net Operating Assets : 0.09 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Innovita Biological Technology Co's operating assets for the quarter that ended in Sep. 2024 was ¥308.4 Mil. Innovita Biological Technology Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥124.3 Mil. Innovita Biological Technology Co's Total Assets for the quarter that ended in Jun. 2024 was ¥2,122.2 Mil. Therefore, Innovita Biological Technology Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.09.


Innovita Biological Technology Co Scaled Net Operating Assets Historical Data

The historical data trend for Innovita Biological Technology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co Scaled Net Operating Assets Chart

Innovita Biological Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.13 0.51 0.22 0.26 0.08

Innovita Biological Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.08 0.08 0.09 0.09

Competitive Comparison of Innovita Biological Technology Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Innovita Biological Technology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovita Biological Technology Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovita Biological Technology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Innovita Biological Technology Co's Scaled Net Operating Assets falls into.


;
;

Innovita Biological Technology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Innovita Biological Technology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(368.609-220.652)/1942.574
=0.08

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2065.655 - 1697.046
=368.609

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=223.647 - 1.037 - 1.958
=220.652

Innovita Biological Technology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(308.354-124.304)/2122.205
=0.09

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2170.134 - 1861.78
=308.354

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=126.424 - 0.525 - 1.595
=124.304

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovita Biological Technology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovita Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Executives
Chen Fu Kang senior management
Zhang Xiao Gang Directors, senior managers
Zhang Xiu Jie Directors, senior managers
Chen Ting You Director, core technical staff
Wang Heng Qiang Core technical personnel
Zhao Xiu Juan Directors, senior managers
Ding Zhi Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines